RRC ID 52599
Author Takahashi J, Murakami M, Mori T, Iwahashi H.
Title Verification of radiodynamic therapy by medical linear accelerator using a mouse melanoma tumor model.
Journal Sci Rep
Abstract Combined treatment with 5-aminolevulinic acid (5-ALA) and X-rays improves tumor suppression in vivo. This is because the accumulated protoporphyrin IX from 5-ALA enhances the generation of ROS by the X-ray irradiation. In the present study, a high-energy medical linear accelerator was used instead of a non-medical low energy X-ray irradiator, which had been previously used. Tumor-bearing mice implanted with B16-BL6 melanoma cells were treated with fractionated doses of irradiation (in total, 20 or 30 Gy), using two types of X-ray irradiator after 5-ALA administration. Suppression of tumor growth was enhanced with X-ray irradiation in combination with 5-ALA treatment compared with X-ray treatment alone, using both medical and non-medical X-ray irradiators. 5-ALA has been used clinically for photodynamic therapy. Thus, "radiodynamic therapy", using radiation from medical linacs as a physical driving force, rather than the light used in photodynamic therapy, may have potential clinical applications.
Volume 8(1)
Pages 2728
Published 2018-2-9
DOI 10.1038/s41598-018-21152-z
PII 10.1038/s41598-018-21152-z
PMID 29426920
PMC PMC5807383
MeSH Aminolevulinic Acid / pharmacology* Animals Melanoma, Experimental / metabolism Melanoma, Experimental / pathology Melanoma, Experimental / therapy* Mice Mice, Inbred C57BL Particle Accelerators / instrumentation* Photochemotherapy / methods* Photosensitizing Agents / pharmacology* Protoporphyrins / metabolism Reactive Oxygen Species / metabolism* Tumor Cells, Cultured X-Rays
IF 3.998
Times Cited 11
Resource
Human and Animal Cells B16/BL6(RCB2638)